» Articles » PMID: 14087622

COMPONENTS OF GUINEA PIG COMPLEMENT. II. SEPARATION OF SERUM FRACTIONS ESSENTIAL FOR IMMUNE HEMOLYSIS

Overview
Journal J Exp Med
Date 1963 Nov 1
PMID 14087622
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The elution characteristics from DEAE cellulose are presented for four components of guinea pig serum, which are capable of interacting sequentially with sheep erythrocytes sensitized with antibody and the first, fourth, and second components of complement (EAC'1,4,2) to cause immune hemolysis, and information is given regarding some of the properties of these components, termed C'3c, C'3b, C'3a, and C'3d. All can react in the presence of ethylene-diaminetetraacetate, and are non-dialyzable. C'3c is quite stable at 56 degrees C, but is rapidly inactivated at low pH or by contact with hydrazine or ammonium hydroxide. C'3b is moderately heat-stable, quite susceptible to low pH, and less readily destroyed by hydrazine. C'3a is very heat-labile, but relatively stable at low pH, while C'3d is heat-labile, sensitive to low pH, and insensitive to bydrazine. EAC'1,4,2 reacts with C'3c to form EAC'1,4,2,3c, which reacts then with C'3b to give the intermediate, EAC'1,4,2,3cb. The following reaction with C'3a yields EAC'1,4,2,3cba, which reacts finally with C'3d to give EAC'1,4, 2,3cbad (E*). The first and last reactions proceed moderately well at 0 degrees C, but more rapidly at 30-37 degrees C. The reaction with C'3b is almost completely inhibited at 0 degrees C, while that involving C'3a proceeds almost as rapidly at 0 degrees C as at higher temperatures. EAC'1,4,2,3cba cells have an increased fragility as compared with the other intermediate forms. Depletion studies with purified fractions and appropriate intermediate complexes showed a high degree of depletion of C'3c, somewhat less of C'3b, and little or no depletion of C'3a from the fluid phase. Examination of a beta(1C) globulin prepared from fresh human serum revealed high C'3c and C'3b activity, and very little C'3a or C'3d.

Citing Articles

Absence of CD59 in Guinea Pigs: Analysis of the Genome Suggests the Evolution of a Pseudogene.

Boshra H, Zelek W, Hughes T, Rodriguez de Cordoba S, Morgan B J Immunol. 2017; 200(1):327-335.

PMID: 29167230 PMC: 5739282. DOI: 10.4049/jimmunol.1701238.


THE HEMOLYSIS OF RED CELLS FROM PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA BY PARTIALLY PURIFIED SUB-COMPONENTS OF THE THIRD COMPLEMENT COMPONENT.

YACHNIN S J Clin Invest. 1965; 44:1534-46.

PMID: 14332166 PMC: 292635. DOI: 10.1172/JCI105260.


ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.

Nilsson U, MUELLER-EBERHARD H J Exp Med. 1965; 122:277-98.

PMID: 14316946 PMC: 2138056. DOI: 10.1084/jem.122.2.277.


THE INITIATION AND ENHANCEMENT OF HUMAN RED CELL LYSIS BY ACTIVATORS OF THE FIRST COMPONENT OF COMPLEMENT AND BY FIRST COMPONENT ESTERASE; STUDIES USING NORMAL RED CELLS AND RED CELLS FROM PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.

YACHNIN S, RUTHENBERG J J Clin Invest. 1965; 44:518-34.

PMID: 14278168 PMC: 292519. DOI: 10.1172/JCI105165.


PH OPTIMA IN IMMUNE HEMOLYSIS: A COMPARISON BETWEEN GUINEA PIG AND HUMAN COMPLEMENT.

YACHNIN S, RUTHENBERG J J Clin Invest. 1965; 44:149-58.

PMID: 14254250 PMC: 442027. DOI: 10.1172/JCI105121.


References
1.
MULLER-EBERHARD H . Isolation and description of proteins related to the human complement system. Acta Soc Med Ups. 1961; 66:152-70. View

2.
Taylor A, Leon M . Third component of human complement: resolution into two factors and demonstration of a new reaction intermediate. Proc Soc Exp Biol Med. 1959; 101(3):587-8. DOI: 10.3181/00379727-101-25026. View

3.
MUSCHEL L, Carey W, Baron L . Formation of bacterial protoplasts by serum components. J Immunol. 1959; 82(1):38-42. View

4.
NELSON Jr R . An alternative mechanism for the properdin system. J Exp Med. 1958; 108(4):515-35. PMC: 2136897. DOI: 10.1084/jem.108.4.515. View

5.
MULLER-EBERHARD H, Nilsson U . RELATION OF A beta(1)-GLYCOPROTEIN OF HUMAN SERUM TO THE COMPLEMENT SYSTEM. J Exp Med. 2009; 111(2):217-34. PMC: 2137252. DOI: 10.1084/jem.111.2.217. View